Stomach cancer study: counting affected lymph node areas may predict survival
NCT ID NCT07139418
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is looking at 400 people with stomach cancer who had surgery to remove the tumor and nearby lymph nodes. Researchers want to see if the number of lymph node areas that contain cancer can help predict how long patients will live. The goal is to better understand which patients may have a worse outlook after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better predict outcomes for gastric cancer patients after surgery.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead to direct changes in care, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Gastrointestinal Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, 310000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI-Guided home training boost recovery from gastric cancer surgery?
- Can a new drug combo shrink Hard-to-Treat tumors?
- Can immunotherapy outperform chemo after stomach cancer surgery?
- Can a smart drug home in on Hard-to-Treat cancers?
- Could a smartphone program supervised by AI boost recovery after stomach cancer surgery?
- Can stomach cancer surgery also tame diabetes?